Clinical Trial IDNCT04001114
Lead SponsorUniversity of Maryland, Baltimore
Principal Investigator
Start Date2020-02-01
Completion Date2021-11-01
Study TypeInterventional
PhaseN/A
StatusNot yet recruiting

Purpose

Higher rates and severity of tobacco dependence in people with schizophrenia, as compared with the general population, contribute to the lower life expectancy seen in this population. Dependent tobacco smoking is controlled by how different aspects of cigarette smoking are perceived. There is evidence suggesting that people with schizophrenia differ in how they perceive cigarette smoking, which, if confirmed, would have implications for tailoring treatment interventions for smoking cessation in schizophrenia.

Conditions

ConditionInterventionPhase
Tobacco Dependence, SchizophreniaCombination Product: Sampling Research CigarettesN/A

Eligibility

AgeGenderAccepts Healthy Volunteers
18 Years to 60 YearsAllAccepts Healthy Volunteers